Microbio Co., Ltd.

4128

TW0004128004

Food Processing

End-of-day quote Taipei Exchange Other stock markets 23:00:00 22/05/2024 BST			5-day change	1st Jan Change
40.6 ^TWD	-1.46%		-2.40%	-19.60%

03-07	Microbio Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Microbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Microbio Co.,Ltd. Announces Phase 1 Clinical Trial Data of SNS812

April 28, 2023 at 02:44 pm

Microbio (Shanghai) Co.,Ltd. announced the Phase 1 clinical trial data of SNS812 a broad-spectrum antiviral siRNA for COVID-19 developed jointly by Microbio (Shan Shanghai) Co.,Ltd. and Oneness.

Latest news about Microbio Co., Ltd.

Microbio Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-07	CI
Microbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-10	CI
Microbio Co.,Ltd. Submits 510(K) Application for Medical Device Mb107 Cream to the U.S. FDA	28/09/23	CI
Microbio Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23	CI
Microbio Co.,Ltd. Agrees by US FDA to Proceed with Phase 2 Clinical Trial	02/08/23	CI
Microbio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
Microbio Co.,Ltd. Announces Phase 1 Clinical Trial Data of SNS812	28/04/23	CI
Microbio Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	13/03/23	CI
Microbio Co., Ltd. Announces Cash Dividend for the Year 2022	24/02/23	CI
Microbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/11/22	CI
Microbio Co., Ltd. Establishes Sustainable Development Committee	10/11/22	CI
Grand Industrial to Buy 100% of Pesticides Producer for $114 Million; Shares Rise 3%	03/11/22	MT
Microbio Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22	CI
Microbio Co., Ltd. Announces Executive Changes	11/07/22	CI
Microbio Co., Ltd. Announces Cash Dividend, Payable on August 8, 2022	30/06/22	CI
Microbio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	10/05/22	CI
Microbio Co., Ltd. Approves Cash Dividend for the Year Ended December 31, 2021	15/03/22	CI
Microbio Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	14/03/22	CI
Microbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	04/11/21	CI
Microbio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	06/05/21	CI
Microbio Co., Ltd. Announces Its Subsidiary, Microbioshanghai Receives Written Acceptance from CDE Under NMPA on the NDA Application for the DFU New Drug:On101	13/03/21	CI
Microbio Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	25/02/21	CI
Microbio Co., Ltd. Announces Dividend Distribution for its Subsidiary Cotton Field Organic Co., Ltd	24/02/21	CI
Microbio Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	12/11/20	CI
Microbio Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020	10/08/20	CI

Microbio Co., Ltd. is a Taiwan-based company primarily engaged in the research, development, manufacture, distribution and wholesales of healthcare food products and pharmaceuticals. The Company provides fermentation products, including Tien Chun Bao (TCB) oral solutions; herbal products, including LeeHerb series products, as well as organic foods, including vegetables, fruits, nuts, pastry, seasonings, organic meals and others. In addition, it provides new medicines, including anticancer medicines, medicines for hepatitis, allergy, rheumatoid arthritis and others. The Company mainly distributes its products mainly within domestic market.

Sector

Food Processing

More about the company

Income Statement Evolution

More financial data

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
MICROBIO CO., LTD.	-19.60%	715M
ZHEJIANG NHU COMPANY LTD.	+15.09%	8.35B
BELLRING BRANDS, INC.	+3.37%	7.62B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+1.45%	6.01B
THE SIMPLY GOOD FOODS COMPANY	-6.26%	3.75B
BYHEALTH CO., LTD	-9.86%	3.7B
XIAMEN KINGDOMWAY GROUP COMPANY	-6.55%	1.34B
HERBALIFE LTD.	-28.83%	1.13B
SIRIO PHARMA CO., LTD.	+14.31%	992M
USANA HEALTH SCIENCES, INC.	-10.78%	925M